Columbus Macro’s Bristol-Myers Squibb BMY Stock Holding History

Columbus Macro’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.42M	Buy	+42,034	New	+$2.41M	0.24%	117
2023 Q2	–	Sell	-4,741	Closed	-$331K	–	156
2023 Q1	$331K	Sell	4,741 -43	-0.9%	-$3.03K	0.12%	146
2022 Q4	$344K	Sell	4,784 -140	-3%	-$10.6K	0.13%	142
2022 Q3	$350K	Sell	4,924 -237	-5%	-$17.2K	0.14%	140
2022 Q2	$399K	Buy	5,161 +35	+0.7%	+$2.67K	0.15%	131
2022 Q1	$376K	Sell	5,126 -101	-2%	-$6.78K	0.13%	134
2021 Q4	$326K	Sell	5,227 -340	-6%	-$19.9K	0.11%	137
2021 Q3	$331K	Sell	5,567 -49	-0.9%	-$3.23K	0.11%	133
2021 Q2	$375K	Sell	5,616 -10	-0.2%	-$652	0.12%	131
2021 Q1	$357K	Sell	5,626 -844	-13%	-$52.5K	0.11%	135
2020 Q4	$404K	Sell	6,470 -1,233	-16%	-$75.8K	0.12%	119
2020 Q3	$464K	Sell	7,703 -1,130	-13%	-$68K	0.14%	109
2020 Q2	$519K	Sell	8,833 -2,524	-22%	-$151K	0.14%	89
2020 Q1	$633K	Sell	11,357 -7,072	-38%	-$432K	0.18%	97
2019 Q4	$1.18M	Buy	+18,429	New	+$1.06M	0.26%	79

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Columbus Macro's BMY Position: Q2 2026 in Review

Columbus Macro opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 42,034 shares worth $2.42M. The stake represents 0.24% of the portfolio and ranks #117 among its holdings. This is a return to the name: Columbus Macro previously reported a position in BMY as recently as Q1 2023.

Columbus Macro first reported a position in BMY in Q4 2019 and has held it in 15 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Columbus Macro held 42,034 shares of Bristol-Myers Squibb worth $2.42M as of Q2 2026.
Bristol-Myers Squibb was a new Columbus Macro position in Q2 2026.
Bristol-Myers Squibb made up 0.24% of Columbus Macro's portfolio in Q2 2026, its #117 holding.
Columbus Macro first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 15 quarters since.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Columbus Macro's 13F filing for Q2 2026, filed 22 Jul 2026.